Results 301 to 310 of about 440,074 (404)

Impact of double versus single blastocyst biopsy and vitrification on clinical and neonatal outcomes in PGT cycles: A systematic review and meta‐analysis of embryo retesting

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
Rebiopsied and revitrified blastocysts may be linked to lower pregnancy and live birth rates in single euploid frozen embryo transfer cycles (very low‐quality evidence). Subgroup effects by biopsy day and morphology may hold clinical relevance and guide future study design.
Alessandra A. Vireque   +4 more
wiley   +1 more source

Perinatal outcomes in pregnancies with very and extremely advanced maternal age: An Italian multicenter retrospective cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
Assisted reproduction in women aged ≥45 years increases maternal risks, particularly with donor oocytes, while neonatal outcomes remain unaffected. These findings highlight the importance of personalized counseling and care strategies in very advanced maternal age pregnancies.
Oumaima Ammar   +10 more
wiley   +1 more source

Phosphorylation of peptides by a kinase domain in cyanobactin pathways. [PDF]

open access: yesNat Commun
Castelo-Branco R   +6 more
europepmc   +1 more source

The Paediatric BCG Vaccine Century: From Historical Success to Future Innovations

open access: yesActa Paediatrica, EarlyView.
ABSTRACT Aim The tuberculosis (TB) vaccine, Bacille‐Calmette‐Guérin (BCG), protects infants against severe forms of primary TB. Yet, it does not protect against pulmonary reactivation TB in adults. Methods A literature review was conducted between 1st January and 28th February 2025 using PubMed, Google Scholar and reports of the World Health ...
Stefan H. E. Kaufmann
wiley   +1 more source

The impact of interferon-γ pathway on trained immunity induction by vaccination with Bacille Calmette-Guérin. [PDF]

open access: yesSci Rep
Isachesku E   +9 more
europepmc   +1 more source

Tau‐targeting active immunotherapy slows progression and reduces pathology in mouse models of tauopathy

open access: yesBrain Pathology, EarlyView.
The efficacy of the novel anti‐tau active immunotherapy, p5555kb, was tested using two mouse models of tau pathology. p5555kb inoculation increased the survival rate and reduced tau pathology in tau‐overexpressing P301L mice and decreased tau seeding in the brains of C57BL/6 mice injected with human‐purified Alzheimer's disease tau.
Christopher M. Brown   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy